Humacyte Inc.
(HUMAW)
undefined
undefined%
At close: undefined
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -110.78M | -11.96M | -26.48M | -66.52M | -85.42M |
| Depreciation & Amortization | 7.72M | 8.21M | 8.24M | 8.35M | 6.75M |
| Stock-Based Compensation | 6.83M | 6.18M | 10.15M | 4.69M | 4.46M |
| Other Working Capital | 1.73M | 1.39M | -116.00K | 289.00K | 638.00K |
| Other Non-Cash Items | 16.35M | -74.41M | -54.74M | 103.00K | 1.98M |
| Deferred Income Tax | - | -173.00K | -17.80M | 177.00K | -4.27M |
| Change in Working Capital | 6.57M | 1.03M | -557.00K | -2.37M | 453.00K |
| Operating Cash Flow | -73.31M | -71.13M | -81.19M | -55.57M | -71.79M |
| Capital Expenditures | -2.28M | -1.05M | -220.00K | -318.00K | -8.13M |
| Acquisitions | - | -5.89M | - | 50.00K | - |
| Purchase of Investments | - | -10.11M | -8.00M | - | - |
| Sales Maturities Of Investments | 2.11M | 16.00M | - | - | - |
| Other Investing Acitivies | - | 5.89M | -8.00M | 50.00K | - |
| Investing Cash Flow | -173.00K | 4.84M | -8.22M | -268.00K | -8.13M |
| Debt Repayment | -34.07M | -1.98M | 27.93M | 1.75M | -1.29M |
| Common Stock Repurchased | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - |
| Other Financial Acitivies | 38.57M | 535.00K | 239.05M | 301.00K | 1.22M |
| Financial Cash Flow | 4.51M | -1.45M | 266.98M | 2.05M | -74.00K |
| Net Cash Flow | -68.97M | -67.73M | 177.57M | -53.78M | -79.99M |
| Free Cash Flow | -75.58M | -72.18M | -81.41M | -55.89M | -79.91M |